Evidence map›Paper›PMID 30815971›Full record

ArticleMolecular nutrition & food research2019

Treatment of Caenorhabditis elegans with Small Selenium Species Enhances Antioxidant Defense Systems.

Isabelle Rohn, Stefanie Raschke, Michael Aschner, Simon Tuck, Doris Kuehnelt, Anna Kipp, Tanja Schwerdtle, Julia Bornhorst

Abstract read
In one paragraph

Article in Molecular nutrition & food research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Selenium-EnrichedAntioxidants (Basel, Switzerland) · 2024
    Article
  3. Biomolecules · 2022
    Review
  4. Article
  5. Article
  6. Products Derived fromPharmaceuticals (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Isabelle RohnInstitute of Nutritional Science, University of Potsdam, 14558, Nuthetal, Germany.
Stefanie RaschkeInstitute of Nutritional Science, University of Potsdam, 14558, Nuthetal, Germany.
Michael AschnerAlbert Einstein College of Medicine, 10461, NY, USA.
Simon TuckUmeå Centre for Molecular Medicine, Umeå University, 90187, Umeå, Sweden.
Doris KuehneltInstitute of Chemistry, Analytical Chemistry, NAWI Graz, University of Graz, 8010, Graz, Austria.
Anna KippInstitute of Nutrition, Friedrich Schiller University Jena, 07743, Jena, Germany.
Tanja SchwerdtleInstitute of Nutritional Science, University of Potsdam, 14558, Nuthetal, Germany.
Julia BornhorstInstitute of Nutritional Science, University of Potsdam, 14558, Nuthetal, Germany.

Funding

Mechanisms of Manganese NeurotoxicityR01ES010563 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 2001 to 2026
$11.9M
Mechanisms of Methylmercury Induced Neuron ToxicityR01ES007331 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 1996 to 2026
$10.6M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Genetic Modulation of MeHg-Induced Oxidative Stress in the Developing BrainR01ES020852 · NIEHS · VANDERBILT UNIVERSITY · PI ASCHNER, MICHAEL · 2012 to 2016
$1.8M
Genetic Susceptibility to Manganese NeurotoxicityR21ES025415 · NIEHS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ASCHNER, MICHAEL · 2016 to 2017
$459k
Austrian Science FundAustrian Science Fund FWF I 2262Caenorhabditis Genetics CenterDFG Research Unit TraceAgeGerman Research Foundation BO 4103/2-1German Research Foundation FOR 2558German Research Foundation I 2262-N28German Research Foundation SCHW 903/9-1NIEHS NIH HHS P40 OD010440NIEHS NIH HHS R01 10563NIEHS NIH HHS R01 ES007331NIEHS NIH HHS R01 ES010563NIEHS NIH HHS R01 ES020852NIEHS NIH HHS R01ES020852NIEHS NIH HHS R01ES07331NIEHS NIH HHS R21 ES025415NIH HHS P40 OD010440NIH Office of Research Infrastructure Programs
6 · The paper itself

Abstract

scopeSmall selenium (Se) species play a key role in Se metabolism and act as dietary sources of the essential trace element. However, they are redox-active and trigger pro- and antioxidant responses. As health outcomes are strongly species-dependent, species-specific characteristics of Se compounds are tested in vivo. METHODS AND

resultsIn the model organism Caenorhabditis elegans (C. elegans), immediate and sustained effects of selenite, selenomethionine (SeMet), and Se-methylselenocysteine (MeSeCys) are studied regarding their bioavailability, incorporation into proteins, as well as modulation of the cellular redox status. While all tested Se compounds are bioavailable, only SeMet persistently accumulates and is non-specifically incorporated into proteins. However, the protection toward chemically-induced formation of reactive species is independent of the applied Se compound. Increased thioredoxin reductase (TXNRD) activity and changes in mRNA expression levels of antioxidant proteins indicate the activation of cellular defense mechanisms. However, in txnrd-1 deletion mutants, no protective effects of the Se species are observed anymore, which is also reflected by differential gene expression data.

conclusionSe species protect against chemically-induced reactive species formation. The identified immediate and sustained systemic effects of Se species give rise to speculations on possible benefits facing subsequent periods of inadequate Se intake.

Indexed as

AnimalsAntioxidantsCaenorhabditis elegansCaenorhabditis elegans ProteinsGene Expression RegulationMutationSelenious AcidSeleniumSelenium CompoundsSelenocysteineSelenomethioninetert-ButylhydroperoxideThioredoxin Reductase 1AntioxidantsCaenorhabditis elegans ProteinsSelenious AcidSeleniumSelenium CompoundsSelenocysteineSelenomethionineselenomethylselenocysteinetert-ButylhydroperoxideThioredoxin Reductase 1trxr-1 protein, C elegansantioxidant defense systemscaenorhabditis elegansoxidative stressseleniumselenoproteins

Identifiers

PMID30815971
PMCPMC6499701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.